|Call for Abstract||Abstract Submission Deadline||Abstract Acceptance Notification||Payment Deadline for Accepted Abstract|
|Now||15 October 2022||30 October 2022||1 November 2022|
|BEST ORAL PRESENTATION||BEST POSTER AWARD|
|1st Prize - USD 500
2nd Prize -USD 300
|1st Prize - USD 300
2nd Prize -USD 150
Only the presenting author is required to be registered as a delegate.
You may submit more than one abstract.
Abstract must be written in English in all parts including title, names and affiliations of the authors, abstract text and appendices i.e. table, figure and graph.
Abstract must be original research material that has neither been published nor presented in any meeting at the time of submission.
All original research must be approved by a relevant research ethical committee and the approval should be mentioned in the abstract text. Authors should ensure the abstract is properly reviewed, proof-read and free of grammatical error.
Abstracts can only be submitted electronically through the official Congress website (http://www.klvac.my). Abstract sent by post, fax or email WILL NOT BE ACCEPTED.
If you do not complete the submission process, your information will be held in temporary storage until you return later to complete your submission. Please note that your submission must be completed before the submission deadline.
Abstracts must be SUBMITTED BY 11:59 p.m. (Malaysia time), on THURSDAY, 30 AUGUST 2022. Late submissions will not be accepted.
An acknowledgement notification will be sent to you once you have successfully submitted your abstract/s. If you did not receive the acknowledgment, please contact the Congress Secretariat at email@example.com.
All submitted abstracts will undergo a peer-review process by a panel of reviewers. Accepted abstracts will be selected for either oral or poster presentation. The KLVAC 2022 Scientific Committee reserves the right to re-categorise any accepted abstract. The decision of the committee is final. All accepted abstracts will be published in the Congress Programme book and on the website.
Authors will be notified of the method of presentation (virtual or physical), which will be decided by the KLVAC 2022 Scientific Committee.
Abstract authors will be informed of the status of their abstracts via email by 7 SEPTEMBER 2022.
Judges’ decisions are final and no appeal will be entertained.
Once an abstract is selected, payment for conference registration should be paid before 1 November 2022 to ensure that the abstract is published in the Congress Programme book and website.
Category: Please select the category which BEST describes the content of your abstract. Categories are used for reviewing and indexing purposes.
Presentation Preference: Participants may select the option for oral or poster presentation. However, the Scientific Programme Committee reserves the right to re-categorise any accepted abstract.
Abstract Title: The title is limited to 120 characters excluding spaces and should be brief and relevant. Capitalise each word in the title. Special characters should NOT be used in your title but spelt out instead (e.g. α should be written as alpha, β as beta). Only use standard abbreviations and generic drug names in the title.
Authors and Affiliations: The first author listed must be the Presenting/Attending Author. Type the authors’ names according to the format and example given. When more than one author is listed, use numbers to match authors and institutions. Capitalise words only as required.
Structure: The abstract should have the following sub-headings except for case report and case series.
Layout: Please fill in according to the sections provided. Do not include graphs, tables or illustrations in the abstract.
Word count: The abstract should not exceed 300 words (including section headings i.e. Introduction, Methods, Results and Conclusion.)
Only commonly accepted abbreviations should be used (e.g. OGTT, IGT, ACEI). Less widely recognised abbreviations may be used if introduced on first usage (e.g. ambulatory blood pressure monitoring, ABPM).
Only approved and generic (non-proprietary) drug names should be used.
Do NOT enter the title, authors, or grant information into the abstract body submission field.
Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be printed in the abstract/programme book exactly as submitted.
Access system and epidemiology
Native fistula and graft complications
Central vein and cephalic arch issues
Imaging and miscellaneous
If you have queries regarding online submission or abstract related matters, please email us at firstname.lastname@example.org.